Designer tetrahedral DNA framework-based microfluidic technology for multivalent capture and release of circulating tumor cells

Circulating tumor cells (CTCs) have been recognized as a general biomarker for the early detection, diagnosis and therapy monitoring of cancer. Due to their extreme rarity in peripheral blood, the isolation and analysis of CTCs with high efficiency, high purity and high viability remains a tremendou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chenguang, Xu, Yi, Li, Shuainan, Zhou, Yi, Qian, Qiuling, Liu, Yifan, Mi, Xianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Advanced Materials for Disease Diagnosis edited by Kun Qian; Lin Huang
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272028/
https://www.ncbi.nlm.nih.gov/pubmed/35833198
http://dx.doi.org/10.1016/j.mtbio.2022.100346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272028/
https://www.ncbi.nlm.nih.gov/pubmed/35833198
http://dx.doi.org/10.1016/j.mtbio.2022.100346

Ejemplares similares